TY - JOUR
T1 - CD4(+) CD3(-) accessory cells costimulate primed CD4 T cells through OX40 and CD30 at sites where T cells collaborate with B cells
AU - Kim, Mi-Yeon
AU - Gaspal, Fabrina
AU - Wiggett, HE
AU - McConnell, Fiona
AU - Gulbranson-Judge, AD
AU - Raykundalia, Chandrabal
AU - Walker, Lucy
AU - Goodall, Delia
AU - Lane, Peter
PY - 2003/5/1
Y1 - 2003/5/1
N2 - In this report we identify an accessory cell that interacts with primed and memory T cells at sites where they collaborate with B cells. These cells are distinguished from conventional dendritic cells by their lack of response to FIt3 ligand and their inability to process antigen. Unlike dendritic cells, the CD4(+)CD3(-) cells have little CD80 or CD86 expression but do express high levels of the TNF ligands, OX40 ligand and CD30 ligand. We show that Th2-primed cells express the receptors for these TNF ligands and preferentially survive when cocultured with these cells. Furthermore, we show that the preferential survival of OX40(+) T cells and support of memory T cell help for B cells are linked to their association with CD4(+)CD3(-) cells in vivo.
AB - In this report we identify an accessory cell that interacts with primed and memory T cells at sites where they collaborate with B cells. These cells are distinguished from conventional dendritic cells by their lack of response to FIt3 ligand and their inability to process antigen. Unlike dendritic cells, the CD4(+)CD3(-) cells have little CD80 or CD86 expression but do express high levels of the TNF ligands, OX40 ligand and CD30 ligand. We show that Th2-primed cells express the receptors for these TNF ligands and preferentially survive when cocultured with these cells. Furthermore, we show that the preferential survival of OX40(+) T cells and support of memory T cell help for B cells are linked to their association with CD4(+)CD3(-) cells in vivo.
UR - http://www.scopus.com/inward/record.url?scp=0038066310&partnerID=8YFLogxK
U2 - 10.1016/S1074-7613(03)00110-9
DO - 10.1016/S1074-7613(03)00110-9
M3 - Article
C2 - 12753741
SN - 1074-7613
VL - 18
SP - 643
EP - 654
JO - Immunity
JF - Immunity
ER -